The Arab Drug Company (EGX:ADCI)

The Arab Drug Company Revenue

In the fiscal year ending June 30, 2026, The Arab Drug Company had annual revenue of 1.37B EGP with 22.54% growth. The Arab Drug Company had revenue of 340.88M in the quarter ending June 30, 2026, with 14.87% growth. That makes The Arab Drug Company the 32,542nd largest company in the world by revenue and 119th in Egypt.

• Revenue: 1.37B
• Revenue Growth: +22.54%
• P/S Ratio: 2.23
• Revenue / Employee: 1.19M
• Employees: 1,148
• Market Cap: 3.06B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	1.37B	252.09M	22.54%
Jun 30, 2025	1.12B	332.65M	42.35%
Jun 30, 2024	785.52M	151.79M	23.95%
Jun 30, 2023	633.73M	128.69M	25.48%
Jun 30, 2022	505.04M	-32.01M	-5.96%

Data Source: S&P Global Market Intelligence Last updated: Sep 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error